基本信息
Dr. Aftab Ullah born on August 5, 1986, and is currently serving as an Associate Professor at the School of Medicine, Huaqiao University, Quanzhou campus. Dr. Ullah completed his Ph.D. in Pharmaceutics from China Pharmaceutical University in Nanjing (September 2014 - July 2019).
During his doctoral studies, Dr. Ullah's research was primarily centered on the development of liposomes and polyplexes for drug and gene delivery, specifically targeting liver fibrosis. Following his Ph.D., he pursued Postdoctoral research at Shantou University Medical College, Shantou (December 2019 - December 2021), where he explored the application of mesoporous silica nanoparticles in cancer therapy.
Subsequently, Dr. Ullah held the position of Associate Professor at the School of Pharmacy, Jiangsu University, Zhenjiang (December 2021 - November 2023). His work there involved both research and the supervision of Master's students, with a focus on the use of iron oxide nanoparticles for cancer treatment.
2014/9——2019/7
China Pharmaceutical University > 药学 > 博士学位 > 研究生(博士)毕业
2011/4——2013/4
The Islamia University of Bahawlpur > 药理学 > 哲学硕士学位 > 研究生(硕士)毕业
2005/9——2010/12
Gomal University > 药学 > Doctor of Pharmacy > 大学本科
2023/12——至今
Medicine > Huaqiao University > Associate Professor > To date > Teaching and Research.
Focused on Polyplexes, Liposomes, Iron Oxide, and Hollow mesoporous silica NPs for drug and siRNA/miRNA/mRNA delivery to treat liver fibrosis and Cancer
2021/12——2023/11
Pharmacy > Jiangsu University > Associate Professor > Designing projects related to hybrid mesoporous silica and iron oxide nanoparticles for the treatment of liver cancer. Supervising Master students
2019/12——2021/12
Pharmacy > Shantou University Medical College > Post Doc > Designing projects related to Nucleic acid therapeutics, siRNA for treating liver fibrosis and cancer. Responsible for applying for various research grants under the National Natural Science Foundation of China, Compiling research data